Stock DNA
Pharmaceuticals & Biotechnology
VND Million (Micro Cap)
0
NA
0.00%
-0.21
13.21%
0.00
Revenue and Profits:
Net Sales:
31,081 Million
(Quarterly Results - Jun 2025)
Net Profit:
4,319 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.29%
0%
-5.29%
6 Months
-4.83%
0%
-4.83%
1 Year
19.39%
0%
19.39%
2 Years
28.76%
0%
28.76%
3 Years
40.71%
0%
40.71%
4 Years
10.06%
0%
10.06%
5 Years
51.54%
0%
51.54%
Phong Phu Pharmaceutical JSC for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
1.50%
EBIT Growth (5y)
5.94%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.29
Sales to Capital Employed (avg)
1.13
Tax Ratio
20.37%
Dividend Payout Ratio
84.90%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
20.29%
ROE (avg)
13.67%
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
-1.24
EV to EBITDA
-1.05
EV to Capital Employed
-0.27
EV to Sales
-0.20
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
14.60%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
31,081.20
36,886.40
-15.74%
Operating Profit (PBDIT) excl Other Income
5,682.20
6,097.90
-6.82%
Interest
24.00
12.40
93.55%
Exceptional Items
0.00
0.00
Consolidate Net Profit
4,319.20
4,604.80
-6.20%
Operating Profit Margin (Excl OI)
150.40%
138.10%
1.23%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is -15.74% vs -6.56% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is -6.20% vs -4.71% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
137,547.90
152,171.90
-9.61%
Operating Profit (PBDIT) excl Other Income
24,468.00
27,926.30
-12.38%
Interest
0.00
8.20
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
15,547.50
18,137.90
-14.28%
Operating Profit Margin (Excl OI)
147.30%
151.90%
-0.46%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -9.61% vs 1.06% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -14.28% vs -2.11% in Dec 2023
About Phong Phu Pharmaceutical JSC 
Phong Phu Pharmaceutical JSC
Pharmaceuticals & Biotechnology
Phong Phu Pharmaceutical Joint Stock Company is a Vietnam-based company active in the pharmaceutical industry. The Company manufactures, imports and trades pharmaceutical products. Its pharmaceutical manufacturing factory is located at Binh Tan District, Ho Chi Minh City. It also has a pharmaceutical manufacturing workshop located at District 8, Ho Chi Minh City. The Company is also involved in the manufacturing and trading of milk and its derived products, as well as bread, cake, chocolate, sweets, jam, pasta, noodles, tea, drinking water and non-alcoholic beverages. In addition, it manufactures functional food and trades cosmetic products. The Company is engaged in the provision of trucking services, bus services and car rental services as well.
Company Coordinates 
Company Details
30 - 32 Phong Phu Road, Ward 12, District 8 HO CHI MINH None : None
Registrar Details






